In a 22-year-old woman with low‑normal total testosterone, low‑normal free testosterone, normal fasting insulin, normal thyroid function, normal HbA1c, normal follicle‑stimulating hormone (FSH), luteinizing hormone (LH), prolactin, dehydroepiandrosterone (DHEA‑S), and mildly elevated triglycerides (197 mg/dL), what is the appropriate management?

Management Approach for This 22-Year-Old Woman

This patient does not have hyperandrogenism and does not require androgen-targeted therapy; the primary focus should be on addressing the mildly elevated triglycerides through lifestyle modification and monitoring for metabolic risk factors.

Key Clinical Assessment

This patient's laboratory profile reveals:

• Low-normal testosterone levels (total testosterone 36 ng/dL, free testosterone 7 pg/mL) - these are actually in the lower range but not pathologically deficient
• Normal reproductive hormones (FSH, LH, prolactin, DHEA)
• Normal metabolic markers (fasting insulin 12, HbA1c 5.1%)
• Mildly elevated triglycerides (197 mg/dL)
• Normal thyroid function

Why This Patient Does NOT Need Androgen Therapy

The available guidelines address hyperandrogenism (elevated androgens) 1, 2, not low androgens in young women. The Endocrine Society explicitly recommends against making a diagnosis of androgen deficiency syndrome in healthy women because there is a lack of a well-defined syndrome and data correlating androgen levels with specific signs or symptoms are unavailable 3.

The 2019 Global Consensus Statement on testosterone therapy for women confirms that the only evidence-based indication for testosterone therapy is hypoactive sexual desire disorder (HSDD) in postmenopausal women 4. This patient is:

• Only 22 years old (premenopausal)
• Has no documented sexual dysfunction
• Has normal ovarian and adrenal function (normal FSH, LH, DHEA)

What Actually Needs Attention: The Triglycerides

The mildly elevated triglycerides (197 mg/dL) are the only abnormal finding requiring intervention. The Endocrine Society guidelines on lipid management recommend obtaining a fasting lipid panel in women with metabolic concerns 5. At 197 mg/dL, this is borderline high (normal <150 mg/dL).

Specific Management Steps:

1. Lifestyle Modifications (First-Line):

   • Weight assessment and optimization if BMI elevated
   • Reduce simple carbohydrates and refined sugars
   • Increase omega-3 fatty acids
   • Regular aerobic exercise (150 minutes/week minimum)
   • Limit alcohol consumption

2. Rule Out Secondary Causes:

   • Confirm fasting status was adequate (12+ hours)
   • Screen for undiagnosed diabetes (already done - HbA1c normal)
   • Assess for metabolic syndrome components (need blood pressure, waist circumference)
   • Consider oral contraceptive use (can elevate triglycerides)

3. Monitoring Schedule:

   • Repeat lipid panel in 3 months after lifestyle modifications
   • If triglycerides remain >200 mg/dL or rise further, consider pharmacotherapy (fibrates or omega-3 fatty acids)
   • Annual screening for development of metabolic syndrome

Important Clinical Pitfalls to Avoid

Do not prescribe testosterone therapy based solely on laboratory values in a young, asymptomatic woman. The guidelines are clear that testosterone levels do not predict who will benefit from therapy, and there are no approved formulations for premenopausal women 3. Moreover, androgen levels naturally decline by 50% from the early 20s to mid-40s in normal women 6, so these values may simply represent normal variation.

Do not overlook the triglycerides - while 197 mg/dL seems only mildly elevated, in a 22-year-old woman with otherwise normal metabolic markers, this warrants attention. Hypertriglyceridemia is associated with increased cardiovascular risk, particularly when it develops early 5.

What to Tell the Patient

Reassure her that:

• Her hormone levels are within normal limits for a young woman
• The slightly lower testosterone is not pathological and does not require treatment
• Her insulin sensitivity and glucose metabolism are excellent
• The focus should be on optimizing her triglycerides through diet and exercise
• She should be monitored for metabolic syndrome development given the isolated triglyceride elevation

Follow-Up Plan

• 3 months: Repeat lipid panel after lifestyle modifications
• 6-12 months: Comprehensive metabolic reassessment including blood pressure, waist circumference, and repeat HbA1c
• Annually: Screen for development of metabolic syndrome components, particularly if family history of diabetes or cardiovascular disease